Rebecca Adams
St. John's Institute Of Dermatology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 23, 2026
Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 09, 2026
Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review.
Journal: Allergy
Published: March 11, 2025
Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors.
Journal: Journal for immunotherapy of cancer
Published: January 15, 2025
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.
Journal: Cancer research
Published: August 30, 2024
Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha.
Journal: Allergy
Published: August 14, 2024
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.
Journal: Expert review of clinical immunology
Published: March 27, 2024
Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction.
Journal: Nature communications
Published: December 09, 2023
Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies.
Journal: Oncoimmunology
Published: October 10, 2022
Last Updated: 09/26/2026